Anrikefon
Sponsors
Zhongshan Ophthalmic Center, Sun Yat-sen University, Zhujiang Hospital, The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School, Affiliated Hospital of Guangdong Medical University, Beijing Tsinghua Chang Gung Hospital
Conditions
Gallbladder PolypsGallbladder StonesKidney Diseases, ChronicNephrolithiasisOphthalmic SurgeryOpioid AnalgesiaPatients Who Undergo PancreaticoduodenectomyPostoperative Pain
Phase 2
Safety and Efficacy of Anricfen for Postoperative Analgesia and Rehabilitation Promotion After Pancreaticoduodenectomy.Intervention Measures: For Normal Adults, Administer Ariceptin Injection Intravenously Post-operation at a Dose of 1 μg/Kgevery 8 Hours for Three Consecutive Days After Surgery.
RecruitingNCT07514637
Start: 2025-11-25End: 2026-03-31Target: 35Updated: 2026-04-07
A Study on the Efficacy and Safety of Anrikefon for Postoperative Pain Relief Following Laparoscopic Cholecystectomy
Not yet recruitingNCT07741188
Start: 2026-09-01End: 2028-12-31Target: 144Updated: 2026-08-03
Phase 4
Efficacy and Safety of Anrikefon for Postoperative Analgesia in Ophthalmic Surgery
RecruitingNCT07269106
Start: 2026-01-22End: 2027-12-31Target: 204Updated: 2026-04-01
Anrikefon vs Nalfurafine for Sleep Quality in Hemodialysis Patients With CKD-aP
RecruitingNCT07380113
Start: 2026-06-22End: 2027-12-31Target: 50Updated: 2026-08-25
A Randomized, Double-Blind, Placebo-Controlled Trial of Anrikefon for Postoperative Analgesia After Percutaneous Nephrolithotomy
Not yet recruitingNCT07825142
Start: 2026-10-12End: 2029-12-30Target: 160Updated: 2026-09-17